Bing Xia
Wuhan University
4 Papers
16 Citations
Bing Xia is an academic researcher from Wuhan University. The author has contributed to research in topics: Salmonella & Salmonella typhi. The author has an hindex of 4, co-authored 4 publications.
Chat about Author
Papers
Aptamers That Preferentially Bind Type IVB Pili and Inhibit Human Monocytic-Cell Invasion by Salmonella enterica Serovar Typhi
Qin Pan,Xiao-Lian Zhang,Hong-Yan Wu,Pan-Wen He,Fubin Wang,Ming-Sheng Zhang,Jian-Ming Hu,Bing Xia,Jianguo Wu +8 more
TL;DR: The aptamer S-PS8.4 can serve as a tool for analysis of bacterial type IVB pilus-host cell interactions and may yield information for the development of putative new drugs against S. enterica serovar Typhi bacterial infections, useful both in prevention of infection and in therapeutic treatment.
124
CFP10 and ESAT6 aptamers as effective Mycobacterial antigen diagnostic reagents.
TL;DR: In this article, the authors used a Systematic Evolution of Ligands by Exponential Enrichment (SELEX) technique to screen for a functional ssDNA aptamer "antibody" that specifically bound to ESAT6-CFP10 (CE) protein.
80
Type IVB Pilus Operon Promoter Controlling Expression of the Severe Acute Respiratory Syndrome-Associated Coronavirus Nucleocapsid Gene in Salmonella enterica Serovar Typhi Elicits Full Immune Response by Intranasal Vaccination
Fengling Luo,Yong Feng,Min Liu,Pingfei Li,Qin Pan,Victor Tunje Jeza,Bing Xia,Jianguo Wu,Xiao-Lian Zhang +8 more
TL;DR: Insight is provided into how the type IVB pilus operon promoter controlling SARS-CoV N gene expression in Salmonella might be attractive for a live-vector vaccine against SRAS- CoV infection, for it could induce mucosal, humoral, and cellular immune responses.
18
Deletion of N-glycosylation sites of hepatitis C virus envelope protein E1 enhances specific cellular and humoral immune responses.
Min Liu,Haidan Chen,Fengling Luo,Pingfei Li,Qin Pan,Bing Xia,Zhongtian Qi,Wen-Zhe Ho,Xiao-Lian Zhang +8 more
TL;DR: The data showed that N-linked glycosylation can limit both cellular and antibody response to the HCV E1 protein and deletion of the N-glycosylations sites at N209SS and N305CS of hepatitis C virus envelope protein E1 provided potential applications for the development of DNA vaccine with enhanced immunogenicity.